A Phase I Trial Evaluating the Addition of Lenalidomide to Patients with Relapsed/Refractory Multiple Myeloma Progressing on Ruxolitinib and Methylprednisolone.
James R BerensonAndrea LimonStephanie RiceTahmineh SafaieRalph BocciaHonghao YangMehdi MoeziStephen LimGary SchwartzShahrooz EshaghianMatthew BrobeckRegina SwiftBenjamin M EadesSean BujarskiYohana SebhatRudra RaySusanna KimAshley Del DossoRobert VescioPublished in: Targeted oncology (2024)
This study is registered with ClinicalTrials.gov, NCT03110822, and is ongoing.